Current State of Personalized Genitourinary Cancer Radiotherapy in the Era of Precision Medicine

by Sophia C. Kamran, Jason A. Efstathiou
Published 2021-05-01

Incorporating PSMA-Targeting Theranostics Into Personalized Prostate Cancer Treatment: a Multidisciplinary Perspective

by Thomas S. C. Ng, Xin Gao, Keyan Salari, Dimitar V. Zlatev, Pedram Heidari, Sophia C. Kamran
Published 2021-07-01

The impact of quantitative CT-based tumor volumetric features on the outcomes of patients with limited stage small cell lung cancer

by Sophia C. Kamran, Thibaud Coroller, Nastaran Milani, Vishesh Agrawal, Elizabeth H. Baldini, Aileen B. Chen, Bruce E. Johnson, David Kozono, Idalid Franco, Nitish Chopra, Roman Zeleznik, Hugo J. W. L. Aerts, Raymond Mak
Published 2020-01-01

Characterization of efficacy and toxicity after high-dose pelvic reirradiation with palliative intent for genitourinary second malignant neoplasms or local recurrences after full-d...

by Sophia C. Kamran, MD, Lauren C. Harshman, MD, Mandar S. Bhagwat, PhD, Vinayak Muralidhar, MD, MSc, Paul L. Nguyen, MD, Neil E. Martin, MD, MPH, Stephanie La Follette, BA, Sarah Faso, MPH, Akila N. Viswanathan, MD, MPH, Jason A. Efstathiou, MD, DPhil, Clair J. Beard, MD
Published 2017-04-01

Primary tumor sidedness is an independent prognostic marker for survival in metastatic colorectal cancer: Results from a large retrospective cohort with mutational analysis

by Sophia C. Kamran, Jeffrey W. Clark, Hui Zheng, Darrell R. Borger, Lawrence S. Blaszkowsky, Jill N. Allen, Eunice L. Kwak, Jennifer Y. Wo, Aparna R. Parikh, Ryan D. Nipp, Janet E. Murphy, Lipika Goyal, Andrew X. Zhu, A. John Iafrate, Ryan B. Corcoran, David P. Ryan, Theodore S. Hong
Published 2018-07-01